Different vaccination strategies in spain and its impact on severe varicella and zoster

Vaccine

Volumn 32, Issue 2, 2014, Pages 277-283

  Gil Prieto, Ruth ^a,b   Walter, Stefan ^c   Gonzalez Escalada, Alba ^a   Garcia Garcia, Laura ^a   Marín García, Patricia ^a   Gil de Miguel, Angel ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; Herpes zoster; Hospitalizations; Spain; Vaccine; Varicella

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHICKENPOX; CHILD; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HERPES ZOSTER; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPAIN; TREND STUDY; VACCINATION;

EPIDEMIOLOGY; HERPES ZOSTER; HOSPITALIZATIONS; SPAIN; VACCINE; VARICELLA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HERPES ZOSTER; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; VACCINATION; YOUNG ADULT;

EID: 84890570696     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.008     Document Type: Article

References (34)

1. Becerra J.C., Sieber R., Martinetti G., Costa S.T., Meylan P., Bernasconi E. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 2013, pii: S1201-9712(13)00096-9. 10.1016/j.ijid.2013.01.031.
2. Centers for Disease Control and Prevention (CDC) Varicella death of an unvaccinated, previously healthy adolescent - Ohio, 2009. MMWR Morb Mortal Wkly Rep 2013, 62(April):261-263.
3. Gowin E., Wysocki J., Michalak M. Don't forget how severe varicella can be-complications of varicella in children in a defined Polish population. Int J Infect Dis 2013, pii: S1201-9712(12)01317-3. 10.1016/j.ijid.2012.11.024.
4. Cameron J.C., Allan G., Johnston F., Finn A., Heath P.T., Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 2007, 92:1062-1066.
5. Johnson R.W., Bouhassira D., Kassianos G., Leplège A., Schmader K.E., Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010, 8(June):37.
6. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after the introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002, 287:606-611.
7. Cenoz M.G., Martínez-Artola V., Guevara M., Ezpeleta C., Barricarte A., Castilla J. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain. Hum Vaccin Immunother 2013, 9(January (5)):1172-1176.
8. Marès Bermúdez J., van Esso Arbolave D., Arístegui Fernández J., Ruiz Contreras J., González Hachero J., Merino Moína M., et al. Vaccination schedule of the Spanish association of paediatrics: recommendations 2010. An Pediatr (Barc) 2010, 72(June (6)):433e1-4417e.
9. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D. Shingles Prevention Study Group: a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352(22):2271-2284.
10. Gil-Prieto R., San Martín M., de Andrés A.L., Alvaro-Meca A., González A., de Miguel A.G. Hospital-acquired rotavirus infections in Spain over a ten-year period (1998-2007). Hum Vaccin 2009, 5(11):748-753.
11. Gil-Prieto R., García-García L., Alvaro-Meca A., González-Escalada A., Viguera Ester P., Gil De Miguel A. The burden of hospitalizations for meningococcal infection in Spain (1997-2008). Vaccine 2011, 29(34):5765-5770.
12. Gil Prieto R., San Román Montero J., Gómez Alejandre C., Alvaro Meca L.A., Rivero A., Gil de Miguel A. Epidemiology of pneumococcal meningitis hospitalisations in pediatric population in Spain (1998-2006). Vaccine 2009, 27(20):2669-2673.
13. Ministerio de Sanidad y Consumo Clasificación internacional de enfermedades 9 revisión, modificación clínica 1996, 375-376. Available at: http://www.msssi.gob.es/estadEstudios/estadisticas/normalizacion/clasifEnferm/fichas/home.htm (consulted 11.05.13).
14. Rivero Cuadrado A. El conjunto mínimo básico de datos en el SNS: inicios y desarrollo actual. Rev Fuentes Estadísticas 2000, 49:18-19. Available at: http://www.ingesa.msc.es/estadEstudios/documPublica/pdf/grds-2001.pdf (consulted 10.05.13).
15. Peiro S., Librero J. Evaluación de la calidad a partir del conjunto mínimo de datosbásicos al alta hospitalaria. Rev Neurol 1999, 29:651-661.
16. Wooldridge J. Econometric analysis of cross section and panel data 2010, 130-132. MIT Press, Cambridge, MA. 2nd ed.
17. Gil A., Gil R., Alvaro A., San Martín M., González A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis 2009, 9(May):55.
18. Guillen J.M., Gil-Prieto R., Alvaro A., Gil A. Burden of adult varicella hospitalizations in Spain (2001-2007). Hum Vaccin 2010, 6(August (8)):659-663.
19. Guillén J.M., Samaniego-Colmenero Mde L., Hernández-Barrera V., Gil A. Varicella paediatric hospitalizations in Spain. Epidemiol Infect 2009, 137(April (4)):519-525.
20. Marshall H.S., McIntyre P., Richmond P., Buttery J.P., Royle J.A., Gold M.S., et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes following introduction of varicella vaccine in Australia. Pediatr Infect Dis J 2013, 32(May (5)):530-537. 10.1097/INF.0b013e31827e92b7.
21. Cenoz M.G., Martínez-Artola V., Guevara M., Ezpeleta C., Barricarte A., Castilla J. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain. Hum Vaccin Immunother 2013, 9(May (5)):1172-1176. Epub 2013 Jan 16. 10.4161/hv.23451.
22. Ozaki T. Varicella vaccination in Japan: necessity of implementing a routine vaccination program. J Infect Chemother 2013, 19(April (2)):188-195.
23. Kurugol Z., Halicioglu O., Koc F., Koturoglu G., Aksit S. Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey. Int J Infect Dis 2011, 15(July (7)):e475-e480.
24. Brisson M., Edmunds W.J., Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003, 70(Suppl. 1):S31-S37.
25. Brisson M., Gay N.J., Edmunds W.J., Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002, 20(19-20):2500-2507.
26. Van Hoek A.J., Melegaro A., Zagheni E., Edmunds W.J., Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2011, 29(March (13)):2411-2420.
27. Ward K., Dey A., Hull B., Quinn H.E., Macartney K., Menzies R. Evaluation of Australia's varicella vaccination program for children and adolescents. Vaccine 2013, 31(February (10)):1413-1419. 10.1016/j.vaccine.2012.12.052.
28. Marin M., Meissner H.C., Seward J.F. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008, 122(September (3)):e744-e751. 10.1542/peds.2008-0567.
29. Salvadori M. Preventing varicella: recommendations for routine two-dose varicella immunization in children. Paediatr Child Health 2011, 16(August (7)):415-416.
30. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965, 58(January):9-20.
31. Guzzetta G., Poletti P., Del Fava E., Ajelli M., Scalia Tomba G.P., Merler S., et al. Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol 2013, 177(May (10)):1134-1142.
32. Patel M.S., Gebremariam A., Davis M.M. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol 2008, 29(December (12)):1157-1163.
33. Moreno-Pérez D., Álvarez García F.J., Arístegui Fernández J., Barrio Corrales F., Cilleruelo Ortega M.J., Corretger Rauet J.M., et al. Immunisation schedule of the Spanish Association of Paediatrics: 2013 recommendations. An Pediatr (Barc) 2013, 78(January (1)):59.e1-27.
34. García-Altés A. Systematic review of economic evaluation studies: are vaccination programs efficient in Spain?. Vaccine 2013, 31(March (13)):1656-1665.